Literature DB >> 17502643

The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.

Derek J Hausenloy1, Derek M Yellon.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17502643      PMCID： PMC1955198          DOI： 10.1136/hrt.2007.118828

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  28 in total

1.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

2.  Myocardial reperfusion: a double-edged sword?

Authors:  E Braunwald; R A Kloner
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction.

Authors:  Patrick D Addison; Peter C Neligan; Homa Ashrafpour; Asim Khan; Anguo Zhong; Michael Moses; Christopher R Forrest; Cho Y Pang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-05       Impact factor: 4.733

4.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

5.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

6.  Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion.

Authors:  W R Ginks; H D Sybers; P R Maroko; J W Covell; B E Sobel; J Ross
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

Review 7.  Preconditioning the myocardium: from cellular physiology to clinical cardiology.

Authors:  Derek M Yellon; James M Downey
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans.

Authors:  Igor E Konstantinov; Sara Arab; Rajesh K Kharbanda; Jia Li; Michael M H Cheung; Vera Cherepanov; Gregory P Downey; Peter P Liu; Eva Cukerman; John G Coles; Andrew N Redington
Journal:  Physiol Genomics       Date:  2004-08-10       Impact factor: 3.107

10.  Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs.

Authors:  Gyorgy Andreka; Marton Vertesaljai; Gergely Szantho; Gusztav Font; Zsolt Piroth; Geza Fontos; Eszter D Juhasz; Laszlo Szekely; Zsolt Szelid; Mark S Turner; Houman Ashrafian; Michael P Frenneaux; Peter Andreka
Journal:  Heart       Date:  2007-04-20       Impact factor: 5.994
View more
  9 in total

Review 1.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

2.  AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling.

Authors:  Qutuba G Karwi; Julia Bornbaum; Kerstin Boengler; Roberta Torregrossa; Matthew Whiteman; Mark E Wood; Rainer Schulz; Gary F Baxter
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

3.  Muscle microdialysis to confirm sublethal ischemia in the induction of remote ischemic preconditioning.

Authors:  Arzu Bilgin-Freiert; Joshua R Dusick; Nathan R Stein; Maria Etchepare; Paul Vespa; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-04-10       Impact factor: 6.829

4.  Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response.

Authors:  Shirin Doroudgar; Donna J Thuerauf; Marie C Marcinko; Peter J Belmont; Christopher C Glembotski
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

5.  Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury.

Authors:  Jm Carter; U Buerke; E Rössner; M Russ; S Schubert; H Schmidt; H Ebelt; D Pruefer; A Schlitt; K Werdan; M Buerke
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

6.  Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway.

Authors:  Haiyan Ding; Rong Han; Xueshan Chen; Weirong Fang; Meng Liu; Xuemei Wang; Qin Wei; Nandani Darshika Kodithuwakku; Yunman Li
Journal:  Molecules       Date:  2016-05-30       Impact factor: 4.411

Review 7.  Designing Novel Therapies to Mend Broken Hearts: ATF6 and Cardiac Proteostasis.

Authors:  Erik A Blackwood; Alina S Bilal; Winston T Stauffer; Adrian Arrieta; Christopher C Glembotski
Journal:  Cells       Date:  2020-03-03       Impact factor: 6.600

8.  Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.

Authors:  Erik A Blackwood; Khalid Azizi; Donna J Thuerauf; Ryan J Paxman; Lars Plate; Jeffery W Kelly; R Luke Wiseman; Christopher C Glembotski
Journal:  Nat Commun       Date:  2019-01-14       Impact factor: 17.694

9.  Early Oxidative Stress Response in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Transatlantic Study.

Authors:  Michael Mahmoudi; Juan Guillermo Gormaz; Marcia Erazo; Michael Howard; Cristian Baeza; Martin Feelisch; Nick Curzen; Bartosz Olechowski; Bernadette Fernandez; Magdalena Minnion; Monika Mikus-Lelinska; Mia Meiss; Laurie Lau; Nicolas Valls; Abraham I J Gajardo; Amy Rivotta; Rodrigo Carrasco; Gabriel Cavada; Maria Jesus Vergara; Gabriel Maluenda
Journal:  Oxid Med Cell Longev       Date:  2019-11-13       Impact factor: 6.543
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.